Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings
Conventional chemotherapy offered limited benefits in patients with advanced PSC; however, those who received first-line immunotherapy-based regimens exhibited significantly improved responses.
Authors
- Yuxi Luo (ORCID: https://orcid.org/0000-0003-4963-8526)
- Duanyang Peng
- Zhimin Zeng (ORCID: https://orcid.org/0000-0003-0959-3044)
- Lianxi Liu (ORCID: https://orcid.org/0000-0002-9897-5361)
- Junxing Chen (ORCID: https://orcid.org/0000-0002-7264-5110)
- Xia Wang (ORCID: https://orcid.org/0000-0002-6986-0979)
- Ying Zheng (ORCID: https://orcid.org/0000-0002-5100-9983)
- Anwen Liu (ORCID: https://orcid.org/0000-0003-4012-9717)
- Xiaoli Zeng
- Le Xiong
Institutions
- Nanchang University (CN)
- Ganzhou People's Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2024-12-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_479_24
- Citations
- 1
- Primary Topic
- Metastasis and carcinoma case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.42